(Q43694247)

25 November 2017

title

Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial (English)

1 reference

25 November 2017

0 references

1 reference

1 reference

3

1 reference

25 November 2017

Toni O Kiljander

1

1 reference

25 November 2017

Susan M Harding

2

1 reference

25 November 2017

Mark R Stein

4

1 reference

25 November 2017

Harold S Nelson

5

1 reference

25 November 2017

Jan Ekelund

6

1 reference

25 November 2017

Marta Illueca

7

1 reference

25 November 2017

Ola Beckman

8

1 reference

25 November 2017

Mark B Sostek

9

1 reference

25 November 2017

language of work or name

English

0 references

publication date

15 December 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

25 November 2017

published in

1 reference

25 November 2017

volume

173

1 reference

25 November 2017

issue

10

1 reference

25 November 2017

page(s)

1091-1097

1 reference

Gastroesophageal reflux: a potential asthma trigger

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1167OC

10.1164/RCCM.200507-1167OC

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference